An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance (PMS) to Monitor the Safety and Efficacy of ZIAGEN [Rm] Administered in Korean Patients According to the Prescribing Information
Phase of Trial: Phase IV
Latest Information Update: 25 Sep 2015
At a glance
- Drugs Abacavir (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Adverse reactions
- Sponsors GlaxoSmithKline; ViiV Healthcare
- 22 Sep 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Feb 2011 Additional trial investigator (Cheri Hudson) identified as reported by ClinicalTrials.gov.
- 18 Feb 2011 Actual initiation date (Nov 2010) added as reported by ClinicalTrials.gov.